Share Holdings

FRESENIUS KABI ONCOLOGY LTD.

NSE : NABSE : 532545ISIN CODE : INE575G01010Industry : Pharmaceuticals & DrugsHouse : Fresenius Kabi Oncology - MNC
BSE132.450 (0 %)
PREV CLOSE ( ) 132.45
OPEN PRICE ( ) 132.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 132.45 (20430)
VOLUME 91518
TODAY'S LOW / HIGH ( )132.00 132.60
52 WK LOW / HIGH ( ) 132132.6
NSE
This Company is not listed in NSE
ParticularsAug2016Mar2015var%Sep2013Jun2013var%
Promoter and Promoter Group
Indian Promoters00
    Individuals / Hindu Undivided Family00
    Central Government/State Government(s)00
    Bodies Corporate00
    Financial Institutions / Banks00
    Partnership Firms00
    Promoter Group00
    Employees Welfare Fund00
    Other00
    Any Others (Specify)
Foreign Promoters97.0597.05081810
    Non-Residents Individuals / Foreign Individuals00
    'Bodies Corporate97.0597.05081810
    Institutions00
    Other00
Any Others (Specify)
Total of Promoter and Promoter Group97.0597.05081810
Public Shareholding
Institutions0010.929.911.02
    Mutual Funds / UTI000.230.02105
    Financial Institutions / Banks000.020.045
    Insurance Companies000.220.220
    Foreign Institutional Investors009.478.650.95
    Venture Capital Funds00
    Foreign Venture Capital Investors00
    Alternate Investment Funds00
    Foreign Portfolio investors00
    Provident funds / Pension funds00
    Multilateral & Bileteral Development Financial Institution
    Any Others (Specify)0.980.980
    Central Government / State Government(s)00
    Foreign Financial Institutions / Banks00
    Stressed Assets Stabilisation Fund00
    Foreign Financial Institutions
    State Finance Corporation00
    Foreign Bodies DR00
    Other000.980.980
Non-Institutions2.942.9408.089.091.11
    Bodies Corporate0.080.0801.772.322.37
    Individuals00
    Individual shareholders holding nominal share capital up to Rs. 1 lakh2.452.440.415.395.780.67
    Individual shareholders holding nominal share capital in excess of Rs. 1 lakh000.380.441.36
    NBFCs Registed with RBI00
    Employee Trusts00
    Any Others (Specify)0.540.560.36
    Clearing Members00
    Non Resident Indians0.280.2800.390.40.25
    Directors & their Relatives & Friends00
    Foreign Collaborators00
    Foreign Mutual Fund00
    Trusts00
    Hindu Undivided Families00
    Foreign Corporate Bodies00
    Shares in transit00
    Market Maker00
    ESOP/ESOS/ESPS00
    Societies00
    Escrow Account00
    Any Other0.150.147.140.150.150
Total Public Shareholding2.952.940.3419190
 
Total of Promoter and Public Shareholding10010001001000
 
    Shares held by Custodians and against which Depository Receipts have been issued0000
    American Depository Receipts00
    GDRs
Others00
 
Grand Total10010001001000

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.